Howmet Aerospace vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 82)

Howmet Aerospace

LeaderManufacturing

Enterprise

Pittsburgh aerospace components (NYSE: HWM) at $7.4B 2024 revenue (+12%), adjusted EBITDA $1.9B+ (+27%), stock +102% in 2024; #1 global aerospace fastener, 90%+ of aero engine castings competing with Precision Castparts for Boeing/Airbus.

AI VisibilityBeta
Overall Score
A82
Category Rank
#247 of 290
AI Consensus
61%
Trend
stable
Per Platform
ChatGPT
79
Perplexity
75
Gemini
83

About

Howmet Aerospace Inc. is a Pittsburgh, Pennsylvania-based aerospace components manufacturer — publicly traded on the New York Stock Exchange (NYSE: HWM) as an S&P 500 Industrials component — producing precision investment castings, aerospace fastening systems, titanium structural components, and forged aluminum wheels for commercial aerospace, defense, and commercial transportation through approximately 23,930 employees across 27 manufacturing facilities in the US, Canada, Mexico, France, UK, China, Brazil, Hungary, and Japan. In fiscal year 2024, Howmet reported revenue of $7.4 billion (up 12% year-over-year), adjusted EBITDA of $1.9+ billion (up 27%), adjusted EPS of $2.69 (up 46%), free cash flow of $977 million, and a 102% stock price increase — one of the best-performing industrial stocks of 2024. The company holds the number one global position in aerospace fastening systems, manufactures over 90% of structural and rotating aero engine components, and has invented over 90% of the aluminum alloys that have flown in commercial aircraft. Howmet became an independent publicly traded company on April 1, 2020, following the strategic separation of Arconic Inc. (itself spun out of Alcoa in 2016), tracing its metallurgical heritage to the Pittsburgh Reduction Company founded in 1888 and Austenal founded in 1926. CEO John Plant has led Howmet's performance transformation since the Arconic separation.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

82
Overall Score
90
#247
Category Rank
#9
61
AI Consensus
60
stable
Trend
stable
79
ChatGPT
99
75
Perplexity
99
83
Gemini
83
80
Claude
96
92
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.